Bioregulators Preliminary

Cortagen

Peptide bioregulator

Also known as: Ala-Glu-Asp-Pro

In plain language

Cortagen is a short synthetic peptide marketed as a bioregulator aimed at the brain and nervous system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.

What it is explored for

Cortagen is part of the intriguing family of short peptide bioregulators, and the idea of tissue-specific support for the brain and nervous system is an appealing one. Honestly, though, the evidence is preliminary and comes largely from a single research group, mostly in animals, with little independent replication, so any neurological benefits remain unconfirmed.

  • Studied for nerve and brain tissue support
  • Of interest for nerve repair and recovery
  • Explored within the peptide bioregulator framework
  • Studied for gene-expression effects in neural cells

These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary rating, see the evidence summary below for how strong the science actually is.

How it works

Cortagen is described by its developers as a peptide bioregulator for nerve tissue. The proposed mechanisms come largely from one research group and are not broadly established.

  • Proposed neural support. Early reports describe effects on nerve repair and brain markers in animals, but these claims rest on small, mostly uncontrolled studies.
  • Proposed gene regulation. Developers suggest the peptide can influence gene expression in neural cells, a hypothesis not widely replicated independently.

These mechanisms are preliminary findings from mostly single-source research and are not established in humans.

Evidence summary

Evidence for Cortagen is limited to small, older studies, largely from the developing group, with little independent replication. There are no large, well-controlled human trials, so any neurological benefits remain unproven.

Reported safety & side effects

Human safety data are very limited. Long-term effects, interactions, and risks in people are not established because rigorous trials are lacking.

Human safety dataVery limited; no large controlled trials
Regulatory statusNot FDA-approved; research use only
Long-term effectsUnknown

Frequently asked

Is Cortagen FDA-approved?

No. Cortagen is not approved by the FDA. In some regions it is sold as a supplement, but it is not an approved medicine.

Does it help nerve recovery?

That is unproven in people. Most evidence is from small animal studies by one group, with little independent replication, so neurological benefits are not established.